医学
冲程(发动机)
过度诊断
流行病学
重症监护医学
人口
人口老龄化
疾病
医疗保健
溶栓
疾病管理
中国
环境卫生
精神科
经济增长
帕金森病
经济
心肌梗塞
法学
病理
工程类
内科学
机械工程
政治学
作者
Simiao Wu,Bo Wu,M Liu,Z Chen,W Wang,Craig S. Anderson,Peter Sandercock,Y Wang,Yining Huang,Li Cui,Chuan Qiang Pu,Jianping Jia,T Zhang,X Liu,S Zhang,Peng Xie,Dongsheng Fan,Xunming Ji,Wong K-Sl.,L Wang
标识
DOI:10.1016/s1474-4422(18)30500-3
摘要
With over 2 million new cases annually, stroke is associated with the highest disability-adjusted life-years lost of any disease in China. The burden is expected to increase further as a result of population ageing, an ongoing high prevalence of risk factors (eg, hypertension), and inadequate management. Despite improved access to overall health services, the availability of specialist stroke care is variable across the country, and especially uneven in rural areas. In-hospital outcomes have improved because of a greater availability of reperfusion therapies and supportive care, but adherence to secondary prevention strategies and long-term care are inadequate. Thrombolysis and stroke units are accepted as standards of care across the world, including in China, but bleeding-risk concerns and organisational challenges hamper widespread adoption of this care in China. Despite little supporting evidence, Chinese herbal products and neuroprotective drugs are widely used, and the increased availability of neuroimaging techniques also results in overdiagnosis and overtreatment of so-called silent stroke. Future efforts should focus on providing more balanced availability of specialised stroke services across the country, enhancing evidence-based practice, and encouraging greater translational research to improve outcome of patients with stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI